OPTOMETRY UPDATE FROM BERWICK EYE CENTRE
Date: 31/05/2023 (AEST)
Venue: Shanikas, 55 High Street, Berwick, VIC, 3806
Provider: Berwick Eye Centre
Contact: Ed Hauptman, [E] edhauptman@berwickeye.com, [P] +61419702716
Learning Objectives
- Understand uses and limitations of OCT in assessing suspected optic neuropathy
- Appreciate progress towards treatment of atrophic macular degeneration and uses of OCT and autofluorescence in targeting potential treatments
- How to assess and treat or triage paediatric squint
- Virtual Eye Model for ophthalmic patient education
- The current state of the art form managing choroidal lesion
- Selection of patients for EDOF lenses
Max CPD hours awarded: 1.5
Session Information
Name |
---|
Optic Neuropathy: tricks and traps |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |
Name |
---|
Geographic Atrophy: Is Dry the new wet? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |
Name |
---|
What’s new in Paediatric and Squint 2023 |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |
Name |
---|
One right eye - virtual eye education |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |
Name |
---|
The current state of the art form managing choroidal lesion |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |
Name |
---|
Selection of patients for EDOF lenses |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.25 |